Report Detail
Global Lung Cancer Diagnostic Tests Market Insights, Forecast to 2025
- RnM2849020 |
- 04 February, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
The global Lung Cancer Diagnostic Tests market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Lung Cancer Diagnostic Tests market based on company, product type, end user and key regions.
This report studies the global market size of Lung Cancer Diagnostic Tests in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Lung Cancer Diagnostic Tests in these regions.
This research report categorizes the global Lung Cancer Diagnostic Tests market by top players/brands, region, type and end user. This report also studies the global Lung Cancer Diagnostic Tests market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Advpharma Inc
AIT Austrian Institute of Technology GmbH
Courtagen Life Sciences Inc
DiagnoCure Inc. (Inactive)
BioMark Diagnostics Inc.
BioMarker Strategies LLC
Emory University
Epigenomics AG
GlycoZym
HalioDx SAS
Louisville Bioscience, Inc.
Mayo Clinic US
Market size by Product
Immunoassays
Flow Cytometry
Rapid Tests
Molecular Assays
Tissue Arrays
Circulating Tumor Cells
Pharmacodiagnostics
Biomarkers
Other Diagnostics Methods
Market size by End User
Precision Medicine
Personalized Medicine
Cancer Monitoring
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Lung Cancer Diagnostic Tests market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Lung Cancer Diagnostic Tests market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Lung Cancer Diagnostic Tests companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Lung Cancer Diagnostic Tests submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Lung Cancer Diagnostic Tests are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Lung Cancer Diagnostic Tests market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Lung Cancer Diagnostic Tests Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Lung Cancer Diagnostic Tests Market Size Growth Rate by Product
- 1.4.2 Immunoassays
- 1.4.3 Flow Cytometry
- 1.4.4 Rapid Tests
- 1.4.5 Molecular Assays
- 1.4.6 Tissue Arrays
- 1.4.7 Circulating Tumor Cells
- 1.4.8 Pharmacodiagnostics
- 1.4.9 Biomarkers
- 1.4.10 Other Diagnostics Methods
- 1.5 Market by End User
- 1.5.1 Global Lung Cancer Diagnostic Tests Market Size Growth Rate by End User
- 1.5.2 Precision Medicine
- 1.5.3 Personalized Medicine
- 1.5.4 Cancer Monitoring
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Lung Cancer Diagnostic Tests Market Size
- 2.1.1 Global Lung Cancer Diagnostic Tests Revenue 2014-2025
- 2.1.2 Global Lung Cancer Diagnostic Tests Sales 2014-2025
- 2.2 Lung Cancer Diagnostic Tests Growth Rate by Regions
- 2.2.1 Global Lung Cancer Diagnostic Tests Sales by Regions
- 2.2.2 Global Lung Cancer Diagnostic Tests Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Lung Cancer Diagnostic Tests Sales by Manufacturers
- 3.1.1 Lung Cancer Diagnostic Tests Sales by Manufacturers
- 3.1.2 Lung Cancer Diagnostic Tests Sales Market Share by Manufacturers
- 3.1.3 Global Lung Cancer Diagnostic Tests Market Concentration Ratio (CR5 and HHI)
- 3.2 Lung Cancer Diagnostic Tests Revenue by Manufacturers
- 3.2.1 Lung Cancer Diagnostic Tests Revenue by Manufacturers (2014-2019)
- 3.2.2 Lung Cancer Diagnostic Tests Revenue Share by Manufacturers (2014-2019)
- 3.3 Lung Cancer Diagnostic Tests Price by Manufacturers
- 3.4 Lung Cancer Diagnostic Tests Manufacturing Base Distribution, Product Types
- 3.4.1 Lung Cancer Diagnostic Tests Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Lung Cancer Diagnostic Tests Product Type
- 3.4.3 Date of International Manufacturers Enter into Lung Cancer Diagnostic Tests Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Lung Cancer Diagnostic Tests Sales by Product
- 4.2 Global Lung Cancer Diagnostic Tests Revenue by Product
- 4.3 Lung Cancer Diagnostic Tests Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Lung Cancer Diagnostic Tests Breakdown Data by End User
6 North America
- 6.1 North America Lung Cancer Diagnostic Tests by Countries
- 6.1.1 North America Lung Cancer Diagnostic Tests Sales by Countries
- 6.1.2 North America Lung Cancer Diagnostic Tests Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Lung Cancer Diagnostic Tests by Product
- 6.3 North America Lung Cancer Diagnostic Tests by End User
7 Europe
- 7.1 Europe Lung Cancer Diagnostic Tests by Countries
- 7.1.1 Europe Lung Cancer Diagnostic Tests Sales by Countries
- 7.1.2 Europe Lung Cancer Diagnostic Tests Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Lung Cancer Diagnostic Tests by Product
- 7.3 Europe Lung Cancer Diagnostic Tests by End User
8 Asia Pacific
- 8.1 Asia Pacific Lung Cancer Diagnostic Tests by Countries
- 8.1.1 Asia Pacific Lung Cancer Diagnostic Tests Sales by Countries
- 8.1.2 Asia Pacific Lung Cancer Diagnostic Tests Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Lung Cancer Diagnostic Tests by Product
- 8.3 Asia Pacific Lung Cancer Diagnostic Tests by End User
9 Central & South America
- 9.1 Central & South America Lung Cancer Diagnostic Tests by Countries
- 9.1.1 Central & South America Lung Cancer Diagnostic Tests Sales by Countries
- 9.1.2 Central & South America Lung Cancer Diagnostic Tests Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Lung Cancer Diagnostic Tests by Product
- 9.3 Central & South America Lung Cancer Diagnostic Tests by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Lung Cancer Diagnostic Tests by Countries
- 10.1.1 Middle East and Africa Lung Cancer Diagnostic Tests Sales by Countries
- 10.1.2 Middle East and Africa Lung Cancer Diagnostic Tests Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Lung Cancer Diagnostic Tests by Product
- 10.3 Middle East and Africa Lung Cancer Diagnostic Tests by End User
11 Company Profiles
- 11.1 Advpharma Inc
- 11.1.1 Advpharma Inc Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Advpharma Inc Lung Cancer Diagnostic Tests Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Advpharma Inc Lung Cancer Diagnostic Tests Products Offered
- 11.1.5 Advpharma Inc Recent Development
- 11.2 AIT Austrian Institute of Technology GmbH
- 11.2.1 AIT Austrian Institute of Technology GmbH Company Details
- 11.2.2 Company Business Overview
- 11.2.3 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Products Offered
- 11.2.5 AIT Austrian Institute of Technology GmbH Recent Development
- 11.3 Courtagen Life Sciences Inc
- 11.3.1 Courtagen Life Sciences Inc Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Products Offered
- 11.3.5 Courtagen Life Sciences Inc Recent Development
- 11.4 DiagnoCure Inc. (Inactive)
- 11.4.1 DiagnoCure Inc. (Inactive) Company Details
- 11.4.2 Company Business Overview
- 11.4.3 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Products Offered
- 11.4.5 DiagnoCure Inc. (Inactive) Recent Development
- 11.5 BioMark Diagnostics Inc.
- 11.5.1 BioMark Diagnostics Inc. Company Details
- 11.5.2 Company Business Overview
- 11.5.3 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Products Offered
- 11.5.5 BioMark Diagnostics Inc. Recent Development
- 11.6 BioMarker Strategies LLC
- 11.6.1 BioMarker Strategies LLC Company Details
- 11.6.2 Company Business Overview
- 11.6.3 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Products Offered
- 11.6.5 BioMarker Strategies LLC Recent Development
- 11.7 Emory University
- 11.7.1 Emory University Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Emory University Lung Cancer Diagnostic Tests Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Emory University Lung Cancer Diagnostic Tests Products Offered
- 11.7.5 Emory University Recent Development
- 11.8 Epigenomics AG
- 11.8.1 Epigenomics AG Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Epigenomics AG Lung Cancer Diagnostic Tests Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Epigenomics AG Lung Cancer Diagnostic Tests Products Offered
- 11.8.5 Epigenomics AG Recent Development
- 11.9 GlycoZym
- 11.9.1 GlycoZym Company Details
- 11.9.2 Company Business Overview
- 11.9.3 GlycoZym Lung Cancer Diagnostic Tests Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 GlycoZym Lung Cancer Diagnostic Tests Products Offered
- 11.9.5 GlycoZym Recent Development
- 11.10 HalioDx SAS
- 11.10.1 HalioDx SAS Company Details
- 11.10.2 Company Business Overview
- 11.10.3 HalioDx SAS Lung Cancer Diagnostic Tests Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 HalioDx SAS Lung Cancer Diagnostic Tests Products Offered
- 11.10.5 HalioDx SAS Recent Development
- 11.11 Louisville Bioscience, Inc.
- 11.12 Mayo Clinic US
12 Future Forecast
- 12.1 Lung Cancer Diagnostic Tests Market Forecast by Regions
- 12.1.1 Global Lung Cancer Diagnostic Tests Sales Forecast by Regions 2019-2025
- 12.1.2 Global Lung Cancer Diagnostic Tests Revenue Forecast by Regions 2019-2025
- 12.2 Lung Cancer Diagnostic Tests Market Forecast by Product
- 12.2.1 Global Lung Cancer Diagnostic Tests Sales Forecast by Product 2019-2025
- 12.2.2 Global Lung Cancer Diagnostic Tests Revenue Forecast by Product 2019-2025
- 12.3 Lung Cancer Diagnostic Tests Market Forecast by End User
- 12.4 North America Lung Cancer Diagnostic Tests Forecast
- 12.5 Europe Lung Cancer Diagnostic Tests Forecast
- 12.6 Asia Pacific Lung Cancer Diagnostic Tests Forecast
- 12.7 Central & South America Lung Cancer Diagnostic Tests Forecast
- 12.8 Middle East and Africa Lung Cancer Diagnostic Tests Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Lung Cancer Diagnostic Tests Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Lung Cancer Diagnostic Tests . Industry analysis & Market Report on Lung Cancer Diagnostic Tests is a syndicated market report, published as Global Lung Cancer Diagnostic Tests Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Lung Cancer Diagnostic Tests market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
